Quarterly and annual results disclosed under 8-K Item 2.02.
Mirum Pharmaceuticals, Inc. reported the quarter ended March 31, 2026 results: revenue $159.9 million. Guidance raised.
“in such filing. --- EX-99.1 (EX-99.1) --- Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update – Q1 2026 net product sales of $159.9 million – 2026 net product sales guidance increased to $660 to $680 million – Volixibat VISTAS Phase 2b study met primary endpoint – Brelovitug Phase 2b portion of AZURE-1 study met”
Palomar Holdings, Inc. reported the fiscal quarter ended March 31, 2026 results: net income net income of $42.9 million, EPS $1.57 per diluted share.
“Palomar Holdings, Inc. Reports First Quarter 2026 Results LA JOLLA, Calif. (May 6, 2026) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $42.9 million , or $1.57 per diluted share, for the first quarter of 2026 compared to net income of $42.9 million , or $1.57 per diluted share, for the first quarter of 2025 . Adjusted net”
Pennant Group, Inc. reported first quarter ended March 31, 2026 results: revenue $285.4 million, net income $8.5 million, EPS $0.24.
“quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.32 for the quarter (1) . First Quarter Highlights ▪ Total revenue for the first quarter was $285.4 million, an increase of $75.5 million or 36.0% over the prior year quarter; ▪ Net income for the first quarter was $8.5 million, a increase of $0.7 million or 9.6% over the prior year”
XPEL, Inc. reported first quarter ended March 31, 2026 results: revenue $117.4 million, net income $10.3 million, or $0.37 per basic and $0.37 per diluted share. Guidance initiated.
“or the Exchange Act, except as may be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Ex. 99.1 XPEL Reports Revenue Growth of 13.1% to $117.4 million, EBITDA Growth of 17.8% to $17.0 million in First Quarter 2026 San Antonio, TX – May 6, 2026 – XPEL, Inc. (Nasdaq: XPEL) (the "Company"), a global provider of protective films”
Advantage Solutions Inc. reported the three months ended March 31, 2026 results: revenue $869.6 million, net income $71.8 million. Guidance reaffirmed.
“Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,” “we,” or “our”), a leading business solutions provider to consumer goods manufacturers and retailers, today reported financial results for the three months ended March 31, 2026. Revenues for the three months ended March 31, 2026 were $869.6 million compared with $821.8 million, and net loss was $71.8 million compared with a net loss of $56.1 million.”
Strata Critical Medical, Inc. updated its first quarter ended March 31, 2026 guidance (reaffirmed).
“On May 6, 2026, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Remitly Global, Inc. reported first quarter ended March 31, 2026 results: revenue $452.8 million, net income $49.1 million. Guidance raised.
“• Revenue totaled $452.8 million, compared to $361.6 million, up 25%. • Net income was $49.1 million, compared to $11.4 million, up 332%.”
TScan Therapeutics, Inc. reported first quarter ended March 31, 2026 results: revenue $1.0 million, net income $28.7 million.
“Revenue: Revenue for the first quarter of 2026 was $1.0 million, compared to $2.2 million for the first quarter of 2025. The decrease was primarily due to timing of research activities pursuant to the Company’s collaboration agreement with Amgen. R&D Expenses: Research and development (R&D) expenses for the first quarter of 2026 were $21.9 million, compared to $29.8 million for the first quarter of 2025. The decrease of $7.9 million was primarily driven by the timing in the purchase of supplies and consumables, as well as savings in connection with the Company’s previously announced strategy to prioritize the clinical development of its heme program. R&D expenses included non-cash stock compensation expense of $1.2 million and $1.7 million for the first quarter of 2026 and 2025, respectively. G&A Expenses: General and administrative (G&A) expenses for the first quarter of 2026 were $8.2 million, compared to $8.6 million for the first quarter of 2025. The decrease of $0.4 million was pr”
UWM Holdings Corp reported first quarter ended March 31, 2026 results: revenue $901.4 million, net income $170.4 million, EPS $0.09.
“$44.9 billion for the first quarter 2026, up 39% year-over-year, and the second-highest first quarter production in company history. The Company reported 1Q26 total revenue of $901.4 million, net income of $170.4 million and adjusted EBITDA of $160.9 million. Mat Ishbia, Chairman, Chief Executive Officer and President of UWMC, said, “ Q1 was an exceptional quarter”
Trinity Capital Inc. reported the first quarter ended March 31, 2026 results: revenue $90.1 million, net income $44.5 million, EPS $0.53 per basic share.
“a leading alternative asset manager, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights • Total investment income of $90.1 million, an increase of 37.8% year-over-year. • Net investment income (“NII”) of $44.5 million, or $0.53 per basic share. NII grew 37.4% year-over-year. • Net increase in net assets”
Reynolds Consumer Products Inc. reported the first quarter ended March 31, 2026 results: revenue $877 million, net income $59 million, EPS $0.28 per diluted share. Guidance reaffirmed.
“we are encouraged by our progress and the resiliency of our business, and we are reiterating our 2026 earnings outlook.” First Quarter 2026 Highlights • Net Revenues of $877 million compared to $818 million in Q1 2025 ◦ Retail Net Revenues of $804 million compared to $767 million in Q1 2025 ◦ Retail volumes increased 2%; excluding foam Retail volumes”
Arcutis Biotherapeutics, Inc. reported the quarter ended March 31, 2026 results: revenue $105.4 million.
“--- EX-99.1 (EX-99.1) --- Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update • Q1 2026 net product revenue for ZORYVE® (roflumilast) was $105.4 million, a 65% increase compared to Q1 2025, and a 17% decrease compared to Q4 2025 • Continued strong demand for ZORYVE despite typical Q1 seasonality, with continued growth in share of”
Bogota Financial Corp. reported the three months ended March 31, 2026 results: net income $706,000, EPS $0.06 per basic and diluted share.
“reported net income for the three months ended March 31, 2026 of $706,000, or $0.06 per basic and diluted share”
Ethos Technologies Inc. reported first quarter ended March 31, 2026 results: revenue $193.1 million, net income $(166.4) million, EPS $(3.57) per share. Guidance raised.
“in such a filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Ethos Reports First Quarter Fiscal Year 2026 Financial Results • Q1 Revenue grew 104% year-over-year to $193 million • Q1 Direct Channel Revenue grew 136% year-over-year to $146 million • Q1 Third-Party Revenue grew 42% year-over-year to $47 million Austin, TX — May 6, 2026 — Ethos (Nasdaq:”
Root, Inc. reported the quarter ended March 31, 2026 results: net income $36 million.
“This is reflected in our results: • Delivered record profitability , nearly doubling net income year-over-year to $36 million”
Xperi Inc. reported first quarter ended March 31, 2026 results: revenue $114.2, net income $(7.8), EPS $(0.17). Guidance reaffirmed.
“We remain on track for our 2026 goals and reaffirm our financial guidance for the year.” Financial Highlights Q1 FY26 Q1 FY25 GAAP ($ millions, except per share data) Revenue $ 114.2 $ 114.0 GAAP operating income (loss) $ 2.2 $ (16.4 ) GAAP net loss $ (7.8 ) $ (18.4 ) GAAP diluted net loss per share $ (0.17 ) $ (0.41 ) Non-GAAP* ($ millions, except per share”
Aeva Technologies, Inc. reported the quarter ended March 31, 2026 results: revenue $6.3 million, EPS GAAP net loss per share of $0.56.
“First Quarter 2026 Financial Highlights • Total Available Liquidity o Total available liquidity of $224.5 million as of March 31, 2026, consisting of $99.5 million in cash, cash equivalents and marketable securities and $125.0 million in an available facility • Revenue o Revenue of $6.3 million in Q1 2026, compared to revenue of $3.4 million in Q1 2025 • GAAP and Non-GAAP Operating Loss* o GAAP operating loss of $35.1 million in Q1 2026, compared to GAAP operating loss of $30.4 million in Q1 2025 o Non-GAAP operating loss of $25.8 million in Q1 2026, compared to non-GAAP operating loss of $25.9 million in Q1 2025 • GAAP and Non-GAAP Net Loss per Share* o GAAP net loss per share of $0.56 in Q1 2026, compared to GAAP net loss per share of $0.64 in Q1 2025 o Non-GAAP net loss per share of $0.41 in Q1 2026, compared to non-GAAP net loss per share of $0.45 in Q1 2025 • Shares Outstanding o Weighted average shares outstanding of 62.8 million in Q1 2026 *Tables reconciling GAAP to non-GAAP me”
DoorDash, Inc. reported the quarter ended March 31, 2026 results: revenue $4.0 billion, net income $184 million. Guidance reaffirmed.
“2026 Key Financial Metrics • Total Orders increased 27% year-over-year (Y/Y) to 933 million. • Marketplace GOV increased 37% Y/Y to $31.6 billion. • Revenue increased 33% Y/Y to $4.0 billion. • GAAP net income attributable to DoorDash, Inc. common stockholders decreased 5% Y/Y to $184 million. • Adjusted EBITDA increased 28% Y/Y to $754 million. Three Months Ended”
HighPeak Energy, Inc. reported first quarter ended March 31, 2026 results: net income net loss of $127.4 million, EPS $1.02 per diluted share.
“HighPeak reported a net loss of $127.4 million for the first quarter 2026, or $1.02 per diluted share”
Green Thumb Industries Inc. reported first quarter ended March 31, 2026 results: revenue $300.2 million, net income $15.4 million, EPS $0.07 per basic and diluted share.
“accordance with U.S. generally accepted accounting principles (“GAAP”), and all currency is in U.S. dollars. Highlights for the first quarter ended March 31, 2026: • Revenue of $300.2 million, an increase of 7.4% over the same period in the prior year. • Cash at quarter end totaled $344.5 million. • GAAP net income of $15.4 million or $0.07 per basic and diluted”
Chime Financial, Inc. reported the quarter ended March 31, 2026 results: revenue $647 million, net income $53 million. Guidance raised.
“first quarter, exceeding our guidance and reflecting disciplined execution. In addition, Q1 benefits from the seasonal tailwind from tax refund-related activity. • Revenue was $647 million, up 25% year-over-year. ◦ Payments revenue grew 15% year-over-year to $433 million, and 19% year-over-year when combined with Outbound Instant Transfer (OIT) revenue. ◦”
CLOVER HEALTH INVESTMENTS, CORP. /DE reported the first quarter ended March 31, 2026 results: revenue $749 million, net income $27 million. Guidance reaffirmed.
“First quarter 2026 GAAP Net Income of $27 million, an improvement of $29 million year-over-year • First quarter 2026 Medicare Advantage membership of 155,773, up 51% year-over-year, and Total revenues of $749 million, up 62% year-over-year”
Guardian Pharmacy Services, Inc. reported the quarter ended March 31, 2026 results: revenue $336.6 million, net income $13.5 million, EPS $0.21. Guidance raised.
“announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results • Revenue of $336.6 million, up 2% year-over-year. • Residents served ended the quarter at approximately 207,000, up 10% year-over-year. • Net Income of $13.5 million, compared to $9.3 million in the”
Royalty Pharma plc reported first quarter of 2026 results: revenue $925 million. Guidance raised.
“Press Release May 6, 2026 R oyalty Pharma reports first quarter 2026 results Portfolio Rece ipts growth o f 10% to $925 million ; Royalty Receipts growth of 13% Net cash provided by operating activities of $718 million Raised full year 2026 guidance: Portfolio Receipts expected to be $3,325 million to $3,450 million”
Taysha Gene Therapies, Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 6, 2026, Taysha Gene Therapies, Inc. reported financial results for the quarter ended March 31, 2026, and recent business highlights.”
Rayonier, L.P. reported the quarter ended March 31, 2026 results: revenue $276.8 million, net income ($12.4) million (or ($0.05) per diluted share), EPS ($0.05) per diluted share.
“FL — May 6, 2026 — Rayonier Inc. (NYSE:RYN) today reported first quarter net loss attributable to Rayonier of ($12.4) million, or ($0.05) per diluted share, on revenues of $276.8 million. This compares to net loss attributable to Rayonier of ($3.4) million, or ($0.02) per diluted share, on revenues of $82.9 million in the prior year quarter. The first quarter”
Lyell Immunopharma, Inc. reported the first quarter ended March 31, 2026 results: net income net loss of $24.2 million.
“Lyell reported a net loss of $24.2 million for the first quarter ended March 31, 2026, compared to a net loss of $52.2 million for the same period in 2025.”
GoodRx Holdings, Inc. reported first quarter of 2026 results: revenue $194.0 million, net income $1.2 million. Guidance raised.
“the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2026 . First Quarter 2026 Highlights • Revenue of $194.0 million • Net income of $1.2 million ; Net income margin of 0.6% • Adjusted Net Income 1 of $23.0 million ; Adjusted Net Income Margin 1 of 11.9% • Adjusted EBITDA 1 of $58.3 million ;”
Texas Pacific Land Corp reported the first quarter of 2026 results: revenue $236.8 million, net income $142.9 million, EPS $2.07 per share (diluted).
“income of $142.9 million for the first quarter of 2026 compared to net income of $123.3 million for the fourth quarter of 2025. Total revenues for the first quarter of 2026 were $236.8 million compared to $211.6 million for the fourth quarter of 2025. The increase in total revenues was primarily due to a $21.4 million increase in oil and gas royalty revenue and a $20.9”
Pattern Group Inc. reported first quarter ended March 31, 2026 results: revenue $774 million, net income $29 million, EPS $0.16.
“in such filing. --- EX-99.1 (EX-99.1) --- Pattern Reports Record First Quarter 2026 Financial Results Delivered Q1 Revenue Growth of 43% Year over Year, for a Record $774 million Delivered Record NRR of 127%, up from 115% in the Prior Year Period LEHI, UT — May 6, 2026 — Pattern Group Inc. (NASDAQ: PTRN), a leader in accelerating brands on global”
biote Corp. reported the first quarter ended March 31, 2026 results: revenue Revenue of $44.9 million, net income Net income of $2.7 million, EPS diluted earnings per share attributable to biote Corp. stockholders of $0.06.
“Results Sales team expansion on track and nearing targeted level Return to procedure growth expected in second half of 2026 First Quarter 2026 Financial Highlights • Revenue of $44.9 million • Gross profit margin of 68.9% • Net income of $2.7 million and diluted earnings per share attributable to biote Corp. stockholders of $0.06, compared to net income of $15.8”
Tarsus Pharmaceuticals, Inc. reported first quarter ended March 31, 2026 results: revenue $145.4 million, net income $7.0 million, EPS $(0.16). Guidance reaffirmed.
“• Product sales, net: were $145.4 million compared to $78.3 million for the same period in 2025, driven by higher volume and improvements in the gross-to-net discount. • License fees and collaboration revenue: were $16.7 million related to a $15.0 million regulatory milestone achieved under the China Out-License and $1.7 million of required China withholding tax associated with this milestone. The milestone payment was recorded on a gross basis, which increased license fees and collaboration revenue by $1.7 million, with an equal offsetting amount recorded as foreign tax expense within provision for income taxes. There were no license fees and collaboration revenue in the same period in 2025. • Cost of sales: were $9.4 million compared to $5.2 million for the same period in 2025, due to manufacturing costs related to XDEMVY, the royalty Tarsus pays on net product sales, and amortization expense for the milestone payments made to our licensor, which is being amortized over its remaining”
Redwire Corp reported full year ended December 31, 2026 results: revenue 450 million to 500 million. Guidance reaffirmed.
“For the full year ended December 31, 2026, Redwire affirms that it is forecasting revenues of $450 million to $500 million.”
Redwire Corp reported first quarter ended March 31, 2026 results: revenue 97.0 million, net income -76.5 million. Guidance reaffirmed.
“tactical network during the Ivy Sting exercises, further integrating the platform into the U.S. Army’s future concept of operations. • Revenues increased 57.9% year-over-year to $97.0 million for the first quarter of 2026. • Sequential and year-over-year improvement in gross margins to 26.6% for the first quarter of 2026. • Net Loss increased by $73.6 million”
DoubleVerify Holdings, Inc. reported first quarter ended March 31, 2026 results: revenue $180.8 million, net income $6.4 million. Guidance reaffirmed.
“DoubleVerify Reports First Quarter 2026 Financial Results Increased Revenue by 10% Year-over-Year to $180.8 Million, Driven by Social and CTV Achieved Net Income of $6.4 Million and Adjusted EBITDA of $55.2 Million, representing a 31% Adjusted EBITDA margin”
Array Technologies, Inc. reported first quarter ended March 31, 2026 results: revenue $223.4, net income ($13.5), EPS ($0.09). Guidance reaffirmed.
“of flagship DuraTrack® product • Reaffirming Full Year 2026 financial guidance 2026 First Quarter Financial Highlights (in millions, except per share) 1Q 2026 Revenue $223.4 Gross margin 28.2% Adjusted gross margin (1) 30.7% Net loss to common shareholders ($13.5) Adjusted EBITDA (1) $28.8 Net loss per basic and diluted common share ($0.09) Adjusted”
Holley Inc. reported first quarter ended March 29, 2026 results: revenue $147.3 million, net income $7.3 million, EPS $0.06 per diluted share.
“Net Sales was $147.3 million compared to $153.0 million last year • Net Income was $7.3 million, or $0.06 per diluted share”
Surrozen, Inc./DE reported the quarter ended March 31, 2026 results: net income $127.5 million, EPS ($11.65) per share.
“Net loss was $127.5 million, or ($11.65) per share for the quarter ended March 31, 2026”
IonQ, Inc. reported first quarter ended March 31, 2026 results: revenue $64.7 million, net income $805.4 million, EPS $2.19. Guidance raised.
“(EX-99.1) --- EX-99.1 Exhibit 99.1 IonQ Announces First Quarter 2026 Financial Results Revenue Exceeds Midpoint of Guidance Range by 30% ● Reported Record GAAP Revenues of $64.7 Million, Representing 755% Year-On-Year Growth, Fueled by Quantum Computing Growth and Expansion of the Quantum Platform ● Raises Full Year Guidance to be between $260 and $270 Million”
Montauk Renewables, Inc. reported the first quarter ended March 31, 2026 results: revenue $46.4 million, net income $5 thousand.
“conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the first quarter ended March 31, 2026. First Quarter Highlights: • Revenues of $46.4 million, increased 9.0 % compared to the first quarter of 2025 • Net income increased $0.5 million, year-over-year • Non-GAAP Adjusted EBITDA of $10.8 million, increased 22.8%”
Aurora Innovation, Inc. reported financial results for quarter ended March 31, 2026.
“On May 6, 2026, Aurora Innovation, Inc. (the “Company”) announced its financial results for its quarter ended March 31, 2026.”
TaskUs, Inc. reported first quarter ended March 31, 2026 results: revenue $306.3 million, net income $24.3 million, EPS $0.26. Guidance reaffirmed.
“TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and next-generation customer experience to the world’s most innovative companies, today announced its results for the first quarter ended March 31, 2026. • Service revenue of $306.3 million, 10.3% year-over-year growth. • Net income of $24.3 million , net income margin of 7.9%. • Adjusted Net Income of $32.8 million , Adjusted Net Income margin of 10.7%. • Diluted EPS of $0.26 , Adjusted EPS of $0.35.”
PureCycle Technologies, Inc. reported first quarter ended March 31, 2026 results: net income $(33.4) million.
“first step, and we intend to continuously refine and evaluate it as our financial performance evolves and matures.” Financial Update Financial Results Net loss for Q1 2026 was $(33.4) million compared to net income of $8.8 million in Q1 2025. Adjusted EBITDA for Q1 2026 was $(30.9) million, compared to $(25.5) million in Q1 2025 primarily related to higher”
Great Elm Group, Inc. reported fiscal third quarter ended March 31, 2026 results: revenue $3.4 million, net income $(13.5) million.
“Total revenue for the third quarter was $3.4 million, compared to $3.2 million for the prior-year period, a 7% increase. • Net loss was $(13.5) million for the third quarter, compared to net loss of $(4.5) million in the prior-year period.”
agilon health, inc. reported the first quarter ended March 31, 2026 results: revenue $1.42 billion, net income $49 million. Guidance raised.
“previously disclosed market exits, as well as payor exits in certain markets resulting from a disciplined approach to contracting focused on profitability. • Total revenue of $1.42 billion in the first quarter 2026 decreased 7% compared to $1.53 billion in the first quarter 2025. Revenue reflects lower year-over-year membership partially offset by improved pricing,”
Sable Offshore Corp. reported first quarter 2026 results: net income net loss of $197.0 million.
“resumed sales of American oil from the Santa Ynez Unit in accordance with the Defense Production Act order from the U.S. Department of Energy. • Reported a net loss of $197.0 million, primarily driven by operating expenses associated with the resumption of oil transportation through the Santa Ynez Pipeline System (the “SYPS”) and the resumption of oil sales,”
Guerrilla RF, Inc. reported first quarter ended March 31, 2026 results: revenue $6.5 million, net income $1.1 million, EPS $0.06.
“Guerrilla RF Reports First Quarter 2026 Results Revenue of $6.5 Million, Up 48% YoY Gross Margin Expands to 69.9%, Up ~880 Basis Points YoY Operating Loss Narrows to Near Breakeven at ($46) Thousand Product Backlog Grows to $8.8 Million”
SmartRent, Inc. reported first quarter ended March 31, 2026 results: revenue $38.7 million, net income $4.4 million.
“solutions for the rental housing industry, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights; • Total Revenue of $38.7 million was down 6% from the prior year, primarily attributable to a large hardware order which has no counterpart in the first quarter of 2026. Core Revenue of $36.6 million was”
Symbotic Inc. reported second quarter of fiscal year 2026 results: revenue $676 million, net income $9 million. Guidance reaffirmed.
“Symbotic reported revenue of $676 million, up 23% year-over-year, and net income of $9 million, compared with a net loss of $10 million in the second quarter of fiscal year 2025. Adjusted EBITDA 1 reached $78 million, more than double the $35 million in the second quarter of fiscal year 2025. Cash and cash equivalents totaled $2.0 billion at the end of the second quarter of fiscal year 2026, up from $1.8 billion at the end of the first quarter of fiscal year 2026.”
Core Scientific, Inc./tx reported first quarter of 2026 results: revenue $115.2 million, net income $347.2 million.
“is accelerating customer discussions and reinforcing the value of our high-density compute infrastructure platform.” First Quarter 2026 Financial Results • Total revenue was $115.2 million compared to $79.5 million in the first quarter of 2025. ◦ Colocation revenue was $77.5 million, up from $8.6 million in the first quarter of 2025, driven by incremental billable”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.